Picture of Genolution logo

225220 Genolution Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Annual cashflow statement for Genolution, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line34,39414,602-5,550-7,209-12,590
Depreciation
Amortisation
Non-Cash Items7,1832,0544501,7274,694
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-16,890-4,4332,3872,009-1,479
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities25,73213,551-1,136-1,433-7,012
Capital Expenditures-5,131-22,545-6,883-12,186-443
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-17,943-28,912-19537,874-5,416
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-23,074-51,457-7,07825,688-5,859
Financing Cash Flow Items238560221
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-15,0929,1507,159373-117
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-10,040-26,615-1,21726,091-13,379